Arthritis Rheumatol April 2023 PMID 36468520

Tocilizumab in Giant Cell Arteritis: Better Understanding the Benefits.

Frank Buttgereit, Andriko Palmowski, Idil Esen, Elisabeth Brouwer

Full text PDF Download social card

Mentions

Peak: 6 in Dec 2022

across 4 sources since Dec 2022

Extended reach

47,575

potential audience

Total likes

Video views

Mentions per month

Dec 2022 – Oct 2024

Where it's discussed

X / Twitter14 posts
News5 articles
YouTube2 videos
Facebook1 posts

AI synopsis

What people are saying

Many social discussions emphasize the importance of understanding Tocilizumab's benefits, using words like 'better understanding' and 'editorial,' indicating respect for the publication. The tone is primarily informative and reflective, with some posts sharing the original editorial to highlight its relevance, illustrating a shared interest in advancing knowledge about GCA treatment.

AgreementModerate agreement

Most discussions acknowledge the article's focus on Tocilizumab's benefits for GCA, showing general consensus that its insights are valuable.

InterestHigh interest

The high interest score reflects active engagement with the topic, as multiple posts share enthusiasm and highlight the significance of new research.

EngagementModerate engagement

Posts include references to the editorial and reposted content, indicating participants are engaging with the material beyond superficial mentions.

ImpactModerate impact

The moderate impact score suggests that while the discussions recognize the importance of the findings, widespread change in practice or perception is still developing.

Abstract in brief

Tocilizumab is a medication used to treat Giant Cell Arteritis (GCA), an inflammatory condition affecting large blood vessels.
The article discusses recent research showing that Tocilizumab can help control GCA symptoms more effectively and with fewer side effects compared to traditional treatments like steroids.
Overall, the study suggests that understanding how Tocilizumab benefits GCA patients could improve how doctors manage and treat the disease in the future.]

Read the full abstract

All mentions

Tocilizumab's Role in Improving Giant Cell Arteritis Treatment

Tocilizumab is used to treat Giant Cell Arteritis, an inflammatory large vessel disease. Recent research indicates it controls symptoms more effectively with fewer side effects compared to steroids, improving disease…

ReumaTimes · May 1, 2023 24 views

Tocilizumab Enhances Giant Cell Arteritis Treatment Effectiveness

Tocilizumab is a medication used to treat Giant Cell Arteritis, an inflammatory condition affecting large blood vessels. Recent research shows it can better control symptoms with fewer side effects than steroids…

ReumaTimes · Oct 17, 2024 0 views

Luis Alberto Ramírez Gómez

@LuisAlb54295075 · X

RT @ACR_Journals: New Editorial from Arthritis & Rheumatology: Tocilizumab in Giant Cell Arteritis: Better Understanding the Benefits htt…

Feb 27, 2023 · 1 share · 162 followers View post →

ACR_Journals

@ACR_Journals · X

New Editorial from Arthritis & Rheumatology: Tocilizumab in Giant Cell Arteritis: Better Understanding the Benefits https://t.co/ucOvPqZTwd

Feb 26, 2023 · 7 likes · 1 share · 14,300 followers View post →

Specialist MD

@rheumatics · X